📌 Key Takeaways
- Topic: Silica as an Abrasive: Hardness, Particle Size and Applications
- Keywords: silica supplier Vietnam
- Published: 2026-11-20 09:09:54
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Fumed Silica CAS 112945-52-5: Identification, Properties and Safety Data
- Silica vs Silicon: What Is the Difference?
- Liu, Y. et al. Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy. Sci. Adv. 6, eabb2695 (2020). Piece CAS PubMed Google Scholar
- Silica as a Polishing Agent: How It Works and Where It Is Used
- Silica Supplier Thailand: Market Overview and Sourcing Options
- National Center for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, 100035, Beijing, China Rui Shi
- Spherical Silica Market 2026: Semiconductor Packaging Demand and Growth Outlook
- Li, S. et al. Tensile‐strained palladium nanosheets for synthetic catalytic therapy and phototherapy. Adv. Mater. 34, 2202609 (2022). Piece CAS Google Scholar
5N Quartz Sand: Purity Specifications, Key Impurities and High-Tech Applications
What is silica (SiO₂)?
EMC filler
What is the difference between fumed silica and precipitated silica?
silica flatting agent Chen, J. et al. Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to sonodynamic treatment of pancreatic cancer. ACS Nano 11, 12849-12862 (2017). Article CAS PubMed Google Scholar
What drives silica raw material prices?
silica whiteness The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.